NEW YORK (GenomeWeb News) – South Korean firm Boram Pharm has filed a patent infringement suit in the US against Life Technologies alleging infringement of a patent covering technology for producing recombinant viruses.

The suit was filed last week in the US District Court for the District of Delaware. Boram claims that Life Technologies is infringing US Patent No. 7,319,001, titled "High throughput system for producing recombinant viruses using site-specific recombination." The patent was issued on Jan. 15, 2008 to Neurogenex, which is now owned by Boram.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.